Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06699212
Title A Study of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck with No Distant Metastases (ECLIPSE)
Acronym ECLIPSE
Recruitment Not yet recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Rakuten Medical, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cancer Clinic Lexington Kentucky 40536 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field